Medical device manufacturers hoping for robust overseas sales face a new slate of regulations from the European Union.
A recent delay in the implementation of these enhanced requirements from 2026 to 2028 offers only some relief. After all, when considering the development lifecycle of medical equipment, two years ultimately seems like an instant. What follows is a high-level overview of the new EU MDR regulations now set to go in force in 2028. Leverage this information to ensure your medical device engineers fully understand the new requirements. Additionally, these regulations also apply to legacy devices currently sold and in-use in Europe. Let’s take a closer look.
Upcoming EU MDR Requirements
New Risk Categories for Medical Devices in Europe
One important addition in the new EU MDR requirements involves the creation of new risk categories for medical devices. As a result, companies need to analyze their existing product line and potentially reclassify some of their devices. Additionally, this examination requires consideration of clinical evaluations, risk assessments, and even new post-market analysis requirements.
In short, medical device manufacturers must spend significant time and resources handling these new risk categories. Reclassification might even result in increased regulatory requirements, an important consideration for these businesses. The EU’s goals for enhanced risk assessment ultimately involve improving both transparency and ultimately, patient safety.
Unique Device Indicator Requirements for Medical Equipment
The new EU MDR also introduces a centralized database, EUDAMED, to track all medical devices in the European Union. As a result, each piece of medical equipment is required to have a unique device indicator (UDI). This is obviously used for indexing and identifying all medical devices in use across the continent. It’s a strategy facilitating the analysis of device performance at both an aggregate and individual level.
A Higher Emphasis on Quality throughout the Medical Device Development Lifecycle
The new MDR also requires medical device makers to strengthen their design and manufacturing processes, emphasizing quality. Having a UDI for each device in the EUDAMED database helps in tracking this information. Additionally, increased requirements for data collection in clinical trials and post-market analysis provide critical insights and information.
Delaying the new MDR requirements provides companies with an opportunity to improve processes and implement the UDI. The stronger data collection requirements for EUDAMED also need to be considered. Ensure your business has the experienced technical talent to help meet these new European requirements for medical devices.
Are You Looking for IT Talent?
When your company needs an influx of IT talent, connect with the experts at The CERES Group. As one of the top technical staffing agencies in Boston, we provide exceptional candidates with the right experience. Schedule a meeting with us to discuss your current and future hiring plans!
